Ontario Brain Institute

What Ontario Brain Institute does

Ontario Brain Institute (OBI) is a provincially funded, Toronto-based not-for-profit research organization established in 2010 to position Ontario as a global leader in brain research, commercialization, and care. OBI operates six Integrated Discovery Programs — ONDRI (neurodegenerative diseases), CAN-BIND (depression biomarkers), CP-NET (cerebral palsy), EpLink (epilepsy), POND (neurodevelopmental disorders), and CONNECT (concussion) — coordinating research across Ontario's academic and clinical institutions. The institute's core technology infrastructure consists of Brain-CODE, a multi-modal neuroinformatics platform that aggregates clinical, imaging, genetic, EEG, and behavioral data; the Centre for Analytics (CfA), which provides AI/ML compute and tooling; and NeuroFL, a proprietary privacy-preserving federated learning platform that enables multi-institutional AI model training without centralizing patient data. OBI serves four primary stakeholder groups: academic researchers and universities, hospital-based clinicians, neurotech startups and industry partners, and patients/families who shape research priorities through advisory committees.

OBI's go-to-market is community- and program-driven rather than commercial. It does not charge for its core platforms or programs; instead, it operates through competitive funding calls (CfA Analytics Initiatives Cohorts 1-4) and entrepreneurship programs (NERVE, NERD, GEEK, CORTEX) that disburse non-dilutive grants to qualifying researchers and startups. Approximately CAD $1.84M in grant funding flowed through NERVE and CfA in 2024-2026 alone. The institute engages industry through a dedicated Industry Relations function led by Anna Han (VP), a portfolio company program (AiimSense, NetraMark, Epiloid, EpiSign, Ophthalmo Corp), and events such as the "Breakthroughs in Brain Science" public talks series and quarterly Brainnovations newsletter.

The organization's revenue is derived entirely from provincial government funding (Government of Ontario), with no disclosed commercial revenue stream. OBI recently extended its reach internationally through a 2026 Indo-French collaboration with AIIMS-Delhi. With 11-50 employees, the institute operates as a lean coordinating body that leverages partner institutions for execution while concentrating brain-domain expertise, AI infrastructure, and patient-community engagement in-house.

Name

Ontario Brain Institute

Legal name

Ontario Brain Institute

Website

http://www.braininstitute.ca

Company type

Private

Founded year

2010

Operating status

Operating

Headcount range

11–50 employees

Short description

Ontario Brain Institute is a provincially funded not-for-profit research organization that operates Brain-CODE (a multi-modal neuroinformatics platform) and the Centre for Analytics to coordinate brain disorder research across six Integrated Discovery Programs, serving Ontario's academic researchers, hospitals, neurotech startups, and patient community.

Ownership category

akta.pro rank

Product category

Neuroscience Research Platforms

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714), Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) (541715), Management, Scientific, and Technical Consulting Services (5416)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Computer Integrated Systems Design (7373), Services-Engineering, Accounting, Research, Management (8700)

akta.pro primary industry

Neurodiagnostic Centers (EEG/EMG/NCS) (HLAFAKAK)

akta.pro secondary industry

Neurorehabilitation Centers (HLAFAFAH)

Keywords

• Brain research platforms
• Neuroinformatics data sharing
• Federated learning healthcare
• Neurotechnology commercialization
• Brain disorder research

Headquarters

HQ city

Toronto

HQ country

Canada

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Others

Revenue model

1. Government Funding: OBI is a provincially funded not-for-profit organization. Funding is provided, in part, by the Government of Ontario. The institute operates through public funding to accelerate discovery and innovation in brain research.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels7 records

Core offering

Ontario Brain Institute operates the Brain-CODE neuroinformatics platform and Centre for Analytics, providing multi-modal data management, sharing, and analysis infrastructure for brain health research across Ontario. It funds and coordinates Integrated Discovery Programs covering cerebral palsy, depression, concussion, neurodevelopmental disorders, epilepsy, and neurodegeneration, while supporting neurotechnology commercialization through programs such as NERVE, NERD, GEEK, and CORTEX.

Product overview

Ontario Brain Institute operates as a not-for-profit organization offering a portfolio of interconnected research platforms, AI-powered analytics tools, and programs. The core infrastructure consists of Brain-CODE (neuroinformatics platform) and the Centre for Analytics (CfA) providing advanced computing, AI/ML capabilities, and the NeuroFL federated learning platform for privacy-preserving data collaboration. Multiple AI-powered tools have been developed through CfA funding including speech/language analysis for mental health diagnosis (Voices for Mental Health), AI-enhanced portable brain imaging (AiimSense), EEG-gene combination frameworks for epilepsy treatment prediction (Epiloid), synthetic data generation for rare disease diagnosis (EpiSign), and depression subtype analysis (NetraMark). OBI also supports neurotechnology innovation through programs like NERVE and conducts community engagement initiatives including the Breaking Stigma, Building Empowerment storytelling project.

Differentiator

Problem solved

Functional benefit

Brands

• Brain-CODE: OBI's neuroinformatics platform for brain research data management, sharing, and analysis.
• Centre for Analytics (CfA)
• NERVE
• GEEK
• NERD
• CORTEX

Products and services

• Brain-CODE OBI's state-of-the-art neuroinformatics platform providing advanced data management, sharing, and analysis capabilities for brain health research, supporting multi-modal data integration including clinical, imaging, genetic, and behavioral data for researchers and clinicians.
• Centre for Analytics (CfA) OBI's initiative accelerating neuroanalytics development through advanced computing, AI/ML methods, cloud computing infrastructure, and federated learning capabilities, supporting researchers and companies developing brain health AI applications.
• NeuroFL Federated Learning Platform Privacy-preserving federated learning platform enabling AI model training across distributed data sources without centralizing sensitive patient information, supporting collaborative brain health research while maintaining data privacy.
• NERVE Program Neurotech Entrepreneurship to Validate Emerging Innovations program providing grant funding and support for Canadian entrepreneurs developing neurotechnology solutions for brain health, neurodiversity, and neurological disorders.
• GEEK Program Growing Expertise in Evaluation and Knowledge Translation program supporting knowledge translation and research impact assessment in brain health.
• NERD Program Neurotech Early Research and Development program supporting early-stage research and development of neurotechnology innovations.
• CORTEX Program Community-Led Real-World Neurotech Experience program supporting scaling of neurotechnology solutions in community settings with patient and advocate involvement.

Quantifiable outcome

• 1 in 3 Ontarians affected by brain disorders
• +2 more outcomes

Named customers14 records

Segments5 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability11 records

Feature3 records

Partnerships

Twelve partnerships are on record, tiered core and minor.

• Epiloid Biotechnology Inc.coreStrategic or Co-development Partner · 19 March 2026Leading research project on machine learning framework combining EEG and genetic data to predict epilepsy treatment response, part of CfA Cohort 3 Analytics Initiatives. Aim is to eliminate trial-and-error approach to epilepsy care by identifying biological markers of drug response.
• EpiSign Inc.coreStrategic or Co-development Partner · 19 March 2026Developing open-source tool to generate synthetic biological data for AI model training in rare disease diagnosis through blood tests, bypassing traditional privacy barriers and data scarcity challenges in brain disorder detection.
• Holland Bloorview Kids Rehabilitation HospitalcoreStrategic or Co-development Partner · 19 March 2026Developing privacy-preserving federated learning pipeline (with Dr. Azadeh Kushki) to identify unique biological subgroups in children with brain-based differences, moving beyond one-size-fits-all care.
• St. Michael's HospitalcoreStrategic or Co-development Partner · 19 March 2026Building predictive models (with Dr. Michael Cusimano) using Brain-CODE CONNECT concussion dataset to generate individualized recovery risk profiles, guiding return-to-work decisions.
• McGill UniversitycoreStrategic or Co-development Partner · 19 March 2026Building secure federated learning testbed (with Dr. Jean-Baptiste Poline) to benchmark AI models for neurodegenerative diseases, evaluating privacy-preserving tools across large neuroimaging datasets.
• Toronto Metropolitan University (IAMLAB)coreStrategic or Co-development Partner · 19 March 2026Developing AI-powered tools (with Dr. April Khademi) to detect early signs of neurodegeneration from routine brain scans, ensuring reliable results across different imaging equipment.
• AIIMS-DelhiminorStrategic or Co-development Partner · 18 February 2026Indo-French collaboration for AI in brain research and diagnosis of neuro disorders, establishing Indo-French Centre for AI in Health at AIIMS New Delhi. OBI's brain health expertise informs this international initiative.
• AiimSense (Kitchener, Ontario)coreStrategic or Co-development Partner · 10 April 2025Developing AI-powered algorithms to enhance resolution of brain images from portable, cost-effective imaging devices, improving accessibility to brain scans and supporting more accurate diagnosis.
• NetraMark (Toronto)coreStrategic or Co-development Partner · 10 April 2025Using mathematically augmented AI to analyze depression treatment outcomes from comprehensive datasets on Brain-CODE, aiming to uncover subtypes of major depression and improve clinical trial success rates.
• Ophthalmo Corp. (University of Waterloo)coreStrategic or Co-development Partner · 10 April 2025Testing multimodal AI technology combining medical texts and images for early diagnosis of eye diseases caused by nerve damage, leveraging advanced language and vision models.
• Dalhousie UniversitycoreStrategic or Co-development Partner · 10 April 2025Multiple projects including AI-driven mental health diagnosis through speech analysis (Dr. Frank Rudzicz) and measurement of psychomotor speed using speech and movement data (Dr. Rudolf Uher).
• Simon Fraser UniversitycoreStrategic or Co-development Partner · 10 April 2025Creating software tools for researchers to identify depression subgroups and personalize treatments based on brain scans and clinical tests using multimodal biotyping approaches.

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

Market position

Competitive moat6 records

Key risks5 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/user/OntarioBrain
• Facebookfacebook.com/OntarioBrainInstitute
• LinkedInlinkedin.com/company/ontario-brain-institute
• Instagraminstagram.com/ontario_brain
• Xx.com/OntarioBrain

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments55 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Ontario Brain Institute